
At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.
Daiichi Sankyo’s PhD Fellowship Program offers early-career scientists a unique opportunity to launch their careers at the forefront of drug development and innovation. This program is designed for recent PhD graduates and provides direct placement into a full-time role while offering structured development, mentorship, and visibility to leadership.
This particular PhD Fellowship will be within the Precision Medicine Department with a core focus on Digital and Computational Pathology.
This role supports the development and evaluation of predictive biomarkers of patient treatment response enabled by computational pathology methods. The position involves both strategic and hands-on responsibilities related to the workflow of biomarker development from exploratory work to further development as companion diagnostics, including study design, model development and evaluation, and data analysis in a cross-functional setting.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
USD$100,960.00 - USD$151,440.00

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need.
For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com.